SavedAdd your journal

Journals / Türkiye Fiziksel Tıp ve Rehabilitasyon Dergisi / 2017 / Cilt: 63 - Sayı: 1

Akupunturun migren ataklarının önlenmesinde klinik etkinliği ve serotonin düzeylerine etkisi

The clinical efficiency of acupuncture in preventing migraine attacks and its effect on serotonin levels

İlknur AKTAŞ
Asuman GEDİKBAŞI
Dilek BOZKURT
Mualla BİÇER
Arsida BAJRAMİ
Nilgün IŞIKSAÇAN
Murat ÇABALAR
Pages
59–65
Publication Date
2022-11-05
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

The number and duration of attacks was found to be significantly lower in both groups, compared to the pre-treatment values (p

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Objectives: This study aims to investigate the efficacy of acupuncture in preventing migraine attacks.Patients and methods: Between December 2013 and June 2014, a total of 54 patients with a diagnosis of migraine in our neurology clinic were randomized into two groups.
📊
Key Findings & Data:Venlafaxine was administered for three months to one group (drug therapy group: 4 males, 21 females; mean age 32.0±9.1 years; range, 18 to 65 years), while the other group was treated with acupuncture (acupuncture group: 5 males, 24 females; mean age 30.3±7.4 years; range, 18 to 65 years).
💡
Conclusion & Impact:The number and duration of attacks was found to be significantly lower in both groups, compared to the pre-treatment values (p
🔬Design:Research Article
📍Scope:2013 Verileri
⚙️Variables:Domain Parameters

Abstract

Objectives: This study aims to investigate the efficacy of acupuncture in preventing migraine attacks.Patients and methods: Between December 2013 and June 2014, a total of 54 patients with a diagnosis of migraine in our neurology clinic were randomized into two groups. Venlafaxine was administered for three months to one group (drug therapy group: 4 males, 21 females; mean age 32.0±9.1 years; range, 18 to 65 years), while the other group was treated with acupuncture (acupuncture group: 5 males, 24 females; mean age 30.3±7.4 years; range, 18 to 65 years). The control group consisted of a total of 29 healthy individuals (7 males, 22 females; mean age 30.3±7.4 years; range 18 to 65 years). Blood serotonin levels were assessed before and after treatment along with visual analog scale (VAS) and Migraine Disability Assessment (MIDAS) in both groups. Results: There was no statistically significant difference in the mean analgesic use before and after the treatment and VAS and MIDAS scores between the acupuncture and drug therapy groups (p>0.05). The number and duration of attacks was found to be significantly lower in both groups, compared to the pre-treatment values (p

Özet

Amaç: Bu çalışmada akupunkturun migren ataklarının önlenmesindeki etkinliği araştırıldı.Hastalar ve yöntemler: Aralık 2013 - Haziran 2014 tarihleri arasında nöroloji kliniğimizde migren tanısını konan toplam 54 hasta rasgele iki gruba ayrıldı. Bir gruba (ilaç tedavisi grubu: 4 erkek, 21 kadın; ort. yaş 32.0±9.1 yıl; dağılım 18-65 yıl) üç ay süreyle venlafaksin uygulanırken, diğer grup (akupunktur grubu: 5 erkek, 24 kadın; ort. yaş 30.3±7.4 yıl; dağılım 18-65 yıl) akupunktur ile tedavi edildi. Kontrol grubu 29 sağlıklı bireyden (7 erkek, 22 kadın; ort. yaş 30.3±7.4 yıl; dağılım 18-65 yıl) oluşuyordu. Her iki grupta da görsel analog ölçeği (GAÖ) ve Migren Özürlülük Değerlendirmesi (MIDAS) ile birlikte tedavi öncesi ve sonrası kan serotonin düzeyleri ölçüldü. Bulgular: Akupunktur ve ilaç grubu arasında tedavi öncesi ve sonrası ortalama analjezik ilaç kullanımı ve GAÖ ve MIDAS skorları açısından istatistiksel olarak anlamlı fark saptanmadı (p>0.05). Atak sayı ve süresi, her iki grupta da tedavi öncesi değerlere kıyasla, anlamlı düzeyde düşük bulundu (p

🔖

Cite This Article

AKTAŞ, İ., GEDİKBAŞI, A., BOZKURT, D., BİÇER, M., BAJRAMİ, A., IŞIKSAÇAN, N., ÇABALAR, M. (2022). Akupunturun migren ataklarının önlenmesinde klinik etkinliği ve serotonin düzeylerine etkisi. Türkiye Fiziksel Tıp ve Rehabilitasyon Dergisi, Cilt: 63 - Sayı: 1, 59–65. https://ajindex.com/articles/628601

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (15)

  1. Buse DC, Rupnow MF, Lipton RB. Assessing and managing all aspects of migraine: migraine attacks, migraine-related functional impairment, common comorbidities, and quality of life. Mayo Clin Proc 2009;84:422-35
  2. Saengjaroentham C, Supornsilpchai W, Ji-Au W, Srikiatkhachorn A, Maneesri-le Grand S. Serotonin depletion can enhance the cerebrovascular responses induced by cortical spreading depression via the nitric oxide pathway. Int J Neurosci 2015;125:130-9
  3. Danese E, Montagnana M, Lippi G. Platelets and migraine. Thromb Res 2014;134:17-22
  4. Schiapparelli P, Allais G, Rolando S, Airola G, Borgogno P, Terzi MG, et al. Acupuncture in primary headache treatment. Neurol Sci 2011;32:15-8
  5. Lu DP, Lu GP. An Historical Review and Perspective on the Impact of Acupuncture on U.S. Medicine and Society. Med Acupunct 2013;25:311-6
  6. Stewart WF, Lipton RB, Whyte J, Dowson A, Kolodner K, Liberman JN, et al. An international study to assess reliability of the Migraine Disability Assessment (MIDAS) score. Neurology 1999;53:988-94
  7. Li Y, Liang F, Yu S, Liu X, Tang Y, Yang X, et al. Randomized controlled trial to treat migraine with acupuncture: design and protocol. Trials 2008;9:57
  8. Zhang Y, Wang L, Liu H, Li N, Li J, Yi J. The design and protocol of acupuncture for migraine prophylaxis: a multicenter randomized controlled trial. Trials 2009;10:25
  9. He Y, Li Y, Nie Z. Typical aura without headache: a case report and review of the literature. J Med Case Rep 2015;9:40
  10. D’Andrea G, D’Amico D, Bussone G, Bolner A, Aguggia M, Saracco MG, et al. Tryptamine levels are low in plasma of chronic migraine and chronic tension-type headache. Neurol Sci 2014;35:1941-5
  11. Reddy DS. The pathophysiological and pharmacological basis of current drug treatment of migraine headache. Expert Rev Clin Pharmacol 2013;6:271-88
  12. Ozyalcin SN, Talu GK, Kiziltan E, Yucel B, Ertas M, Disci R. The efficacy and safety of venlafaxine in the prophylaxis of migraine. Headache 2005;45:144-52
  13. Bulut S, Berilgen MS, Baran A, Tekatas A, Atmaca M, Mungen B. Venlafaxine versus amitriptyline in the prophylactic treatment of migraine: randomized, double-blind, crossover study. Clin Neurol Neurosurg 2004;107:44-8
  14. Cui Y, Shu XO, Gao Y, Wen W, Ruan ZX, Jin F, et al. Use of complementary and alternative medicine by chinese women with breast cancer. Breast Cancer Res Treat 2004;85:263-70
  15. Sahin S, Bicer M, Eren GA, Tas S, Tugcu Tasci AI, et al. Acupuncture relieves symptoms in